Behar Gregory 4
4 · Seres Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Behar Gregory
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-16+23,000→ 23,000 totalExercise: $19.74Exp: 2031-06-15→ Common Stock (23,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 16, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders.